CN1468607A - Recipe of diabetes treating medicine - Google Patents
Recipe of diabetes treating medicine Download PDFInfo
- Publication number
- CN1468607A CN1468607A CNA021159815A CN02115981A CN1468607A CN 1468607 A CN1468607 A CN 1468607A CN A021159815 A CNA021159815 A CN A021159815A CN 02115981 A CN02115981 A CN 02115981A CN 1468607 A CN1468607 A CN 1468607A
- Authority
- CN
- China
- Prior art keywords
- diabetes
- polysaccharide
- aloe
- glossy ganoderma
- insulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 13
- 239000003814 drug Substances 0.000 title abstract description 8
- 241001116389 Aloe Species 0.000 claims abstract description 11
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 20
- 241000222336 Ganoderma Species 0.000 abstract description 12
- 102000004877 Insulin Human genes 0.000 abstract description 10
- 108090001061 Insulin Proteins 0.000 abstract description 10
- 229940125396 insulin Drugs 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 150000004676 glycans Chemical class 0.000 abstract description 7
- 229920001282 polysaccharide Polymers 0.000 abstract description 7
- 239000005017 polysaccharide Substances 0.000 abstract description 7
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 3
- 229930182490 saponin Natural products 0.000 abstract description 3
- 150000007949 saponins Chemical class 0.000 abstract description 3
- 229940006091 aloe polysaccharide Drugs 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- -1 triterpenoid compound Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
- 230000006870 function Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 210000000496 pancreas Anatomy 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004203 pancreatic function Effects 0.000 description 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The diabetes treating medicine is compounded with glossy ganoderma polysaccharide and aloe juice and its main components includes polysaccharide and saponin. Both aloe containing aloe polysaccharide and glossy ganoderma containing polysaccharide and glossy ganoderma triterpenoid compound have blood sugar content lowering effect and can stimulate pancreatic cell to secret insulin, so that they has excellent treating effect on type I and type II diabetes.
Description
Technical field-along with the development of society, enter a higher school on onset diabetes is constantly trend and the health that is seriously threatening China people.Present technique refers to that perplexing the diabetes patient for a long time in solution is in the anti symptom treatment always, rests on the surface and takes stopgap measures, and takes medicine for a long time, changes dressings, and especially some intercurrent diseases all are difficult to cure.Even more serious is some insulin dependent diabetes mellitus (IDDM), uniquely keeps by insulin, and decades are like this.Actually this is not so, and pancreatic function can slowly recover by the treatment of active drug, and characteristics are exactly by improving pancreatic function.Another characteristics can directly be decomposed sugar.
Background technology-current market is about controlling the square medicine of diabetes, and all a lot of both at home and abroad, advertisement is existed everywhere, north and south expert volunteer medical consultation everywhere, and it is high unusual to ask a price, and patient feels frustrated! Powerless! If lean on import with the domestic drug main of controlling diabetes at present especially, domestic brandless, always follow in others' back.
Content-diabetes are because of insulin and hormone secretion deficiency, cause abnormal carbohydrate metabolism, and the sugar in the blood (glucose) increases, and also occur sugar simultaneously in urine, and blood fat and cholesterol in a lot of patient bloods also increase.
Diabetes are chronic diseases, and are gradual, but it has a lot of complication, as arteriosclerosis, the heart, brain, kidney got a hard knock.Severe patient can cause blind, and hyposexuality causes sexual impotence.
We adopt Aloe, and aloetic main component is polysaccharide and Saponin.Aloetic polysaccharide component A Luobolang A and B have the long-term blood sugar reducing function that continues.
Show according to pharmacy portion of northeastern Japan university and Japan's institute joint research: animal experiment begins to descend for 7 hours blood glucose of Aloe, continues constant thereafter.
Other Aloes have the effect of this respect equally.
Aloe is controlled diabetes and mainly contains:
1. the function of blood circulation promoting promotes the metabolism of sugar, decomposes sugar.
2. improve the effect of focus body fluid, promote insulin metabolism.
3. Aloe has the secretory function that promotes the human viscera organ, can secrete more insulin.
4. because the Aloe molecule is especially little, and penetration is strong, can make the pancreas that loses function, restore funcitons makes own excreting insulin gradually, participates in normal function carbohydrate metabolism.
Ganoderma: go out to have the polysaccharide of hypoglycemic activity, gamodcransA and B, GL-1 from compatriot sesame entity separation.
Ganoderma lucidum triterpene (Ganodenic acid) has hypoglycemic activity.
Ganoderan has hypoglycemic activity.
Ganoderma, proteoglycan can be repaired the B cells of pancreas of damage, make the B cells of pancreas excreting insulin, recover the homergy of blood glucose, reduce the tight generation that gets complication of diabetes.
Ganoderma has the ability that pancreas produces insulin that improves, and quickens the pancreas blood circulation, improves body physiological function, and the body insulin secretion is increased, thereby corrects the metabolism disorder of body sugar, protein, fat, returns to normal steady statue.
Ganoderma not only can be treated diabetes, and the hypoglycemia that can avoid antidiabetic drug and insulinize to cause.
Take two groups of contrasts of Ganoderma kimonos insulin, effect is identical as a result.
The high mountain so-and-so: the man, diabetics, blood glucose mM value 11.7 was taken Ganoderma after 45 days, surveyed blood glucose mM value and reduced to 4.9-5.1.The Ganoderma effect is described obviously.
More than both combinations, be an excellent compatibility.Characteristics:
1, Aloe and Ganoderma all contain abundant polysaccharide and Saponin, and also contain whole aminoacid and multiple element.
2, two kinds of medicines no side effects all, no dependence.
3, both have the ability that promotes viscera function equally, play a positive role for the recovery of chronic disease.
4, the both has the effect of the cytoactive of promotion, can make cell regeneration, will be rare compatibility for prolonging life.
5, abundant raw material, Ganoderma also can obtain high yield behind artificial culture.Succeed in developing, not only the diabetes patient will slowly take leave of insulin, and will bring huge economic benefit to country.
Prescription: ganoderan---50%
China's Aloe original juice---50% (dry powder calculates at 1: 199)
Auxiliary shape agent is an amount of.
Claims (1)
- Ganoderan---50%China's Aloe original juice---50% (dry powder calculates at 1: 199)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA021159815A CN1468607A (en) | 2002-06-10 | 2002-06-10 | Recipe of diabetes treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA021159815A CN1468607A (en) | 2002-06-10 | 2002-06-10 | Recipe of diabetes treating medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1468607A true CN1468607A (en) | 2004-01-21 |
Family
ID=34142102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA021159815A Pending CN1468607A (en) | 2002-06-10 | 2002-06-10 | Recipe of diabetes treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1468607A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1795200A4 (en) * | 2004-09-29 | 2010-08-18 | Morinaga Milk Industry Co Ltd | MEDICINE AND FOOD / DRINK FOR THE RELIEF OF HYPERGLYCEMIA |
| CN101326954B (en) * | 2008-07-30 | 2011-11-16 | 江苏大学 | Method for producing feed containing Ganoderma lucidum acid from wheat straw transformed by Ganoderma lucidum and uses therefor |
| EP1882477A4 (en) * | 2005-05-17 | 2012-07-04 | Morinaga Milk Industry Co Ltd | DRUGS, FOOD OR BEVERAGE FOR ENHANCED PANCREATIC FUNCTIONS |
| CN115634241A (en) * | 2022-11-16 | 2023-01-24 | 青岛农业大学 | Preparation method of Shandong ganoderma lucidum extract and application of Shandong ganoderma lucidum extract in preparation of hypoglycemic drugs |
-
2002
- 2002-06-10 CN CNA021159815A patent/CN1468607A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1795200A4 (en) * | 2004-09-29 | 2010-08-18 | Morinaga Milk Industry Co Ltd | MEDICINE AND FOOD / DRINK FOR THE RELIEF OF HYPERGLYCEMIA |
| EP1882477A4 (en) * | 2005-05-17 | 2012-07-04 | Morinaga Milk Industry Co Ltd | DRUGS, FOOD OR BEVERAGE FOR ENHANCED PANCREATIC FUNCTIONS |
| CN101326954B (en) * | 2008-07-30 | 2011-11-16 | 江苏大学 | Method for producing feed containing Ganoderma lucidum acid from wheat straw transformed by Ganoderma lucidum and uses therefor |
| CN115634241A (en) * | 2022-11-16 | 2023-01-24 | 青岛农业大学 | Preparation method of Shandong ganoderma lucidum extract and application of Shandong ganoderma lucidum extract in preparation of hypoglycemic drugs |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101747446A (en) | Method for extracting anti-fatigue acidic ginseng polysaccharide | |
| CA2191714A1 (en) | Therapeutic food composition and method to diminish blood sugar fluctuations | |
| CN1468607A (en) | Recipe of diabetes treating medicine | |
| CN101040911A (en) | Chinese traditional medicine capsule preparation for treating and preventing diabetes and the method of preparing the same | |
| CN117304261A (en) | A kind of yellow catfish swim bladder oligopeptide with hypoglycemic effect and its preparation method and application | |
| CN101953867A (en) | Petroleum ether extract of saussurea involucrate, application preparation method and application thereof | |
| CN110974849A (en) | Compound sea cucumber extract with hypoglycemic activity and preparation method and application thereof | |
| Micossi et al. | Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII) | |
| CN1305404C (en) | Health caring foodstuff with antihypelipidemic and antihyperglycemic function and preparation method thereof | |
| CN102058098A (en) | Health food with efficacy of lowering blood sugar and preparation method thereof | |
| CN1296082C (en) | Medication and health food in use for lowering blood sugar, improving function of intestinal tract and reducing platelet aggergation | |
| CN1148962A (en) | Prescription of oral liquid for regulating blood sugar and blood lipid and preparation thereof | |
| CN1256888A (en) | Sugar-reducing pumpkin bean powder corn flakes | |
| CN1170562C (en) | Medicine for treating tinea | |
| CN104984331A (en) | Solution preparation using biological active multienzyme to restore pancreatic beta-cells and preparation method thereof | |
| CN1357360A (en) | Hypoglycemic biopreparation | |
| CN1470528A (en) | Snake venom enzyme nerve growth factor for treating diabetic concurrent peripheral nervous pathological complication | |
| CN1278716C (en) | Ready prepared Chinese medicine for anti fatigue- and increasitg body energy | |
| CN1463743A (en) | Capsule possessing antisenescent and spot dispelling effect and method for making the same | |
| CN102293817B (en) | Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof | |
| CN1583068A (en) | Health care food for regulating blood sugar and immunologic function | |
| CN1273152C (en) | Capsule for treating diabetes and productive method thereof | |
| CN1957965A (en) | Chinese traditional medicine preparation for treating impotence, and preparation method | |
| CN1068043C (en) | Ginkgo leaf liquor and preparation process | |
| CN118141108A (en) | A mineral ionic liquid and its application in preparing a product having the effect of treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |